In the case of brain tissue, the ability of WWOX to bind and regulate glycogen synthase kinase 3β (GSK-3β) was proved to be important for Alzheimer’s disease [26], in which a frequent WWOX downregulation is found among patients [27]. This evidence concerns the gene WWOX and early-onset autosomal dominant Alzheimer disease.